Late-stage RSV vaccine trials show 'exciting promise,' some scientists say - CNN
- Late-stage RSV vaccine trials show 'exciting promise,' some scientists say CNN
- Pfizer RSV vaccine 82% effective vs severe infection in infants, final data shows Reuters.com
- Pfizer RSV vaccine 82% effective vs. severe infection in infants, final data shows GMA News Online
- View Full Coverage on Google News